Pulmonary Hypertension in the Intensive Care Unit (ICU) - Swiss Survey 1
| ISRCTN | ISRCTN01751283 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN01751283 |
| Secondary identifying numbers | N/A |
- Submission date
- 06/09/2010
- Registration date
- 28/10/2010
- Last edited
- 28/10/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Urs Wenger
Scientific
Scientific
University Hospital Zürich
Rämistrasse 100
Zürich
8091
Switzerland
Study information
| Study design | Prospective multicentre study |
|---|---|
| Primary study design | Observational |
| Secondary study design | Non randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Screening |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | A prospective multicentre study to investigate the prevalence, causes, diagnostic and therapeutic approach of pulmonary hypertension in the Intensive Care Unit (ICU) |
| Study acronym | PHICUSS1 |
| Study objectives | To investigate the prevalence, causes, diagnostic and therapeutic approach of pulmonary hypertension (PH) of any cause in the setting of surgical, medical or interdisciplinary Intensive Care Units (ICUs) of primary, secondary and tertiary Swiss hospitals. |
| Ethics approval(s) | Ethics approval was not required for this study. |
| Health condition(s) or problem(s) studied | Pulmonary hypertension |
| Intervention | The current characteristics, local facilities, diagnostic and therapeutic attitude against PH of the participating ICUs are assessed prior to study beginning by a questionnaire (hospital form). During the study period all consecutive patients admitted to ICU for any reason are screened for presence or suspicion of PH. If PH is present or suspected the most probable causes, diagnostic and therapeutic attitude, clinical, laboratory, haemodynamic data (if measured) and 30 days survival will be assessed by a questionnaire (patient form). Participating centres are asked to complete the hospital form only once, before study begin. Thereafter, during the enrolment period all patients admitted to the participating ICU are screened by use of the patient from. Only if PH is present, suspected or disclosed at ICU admission, or if risk factors for PH were present, additional information will be requested. Data collection will be performed online using an electronic form of the data collection sheet. |
| Intervention type | Other |
| Primary outcome measure | Prevalence of PH of any cause in the setting of surgical, medical or interdisciplinary ICUs. During the planned study period of 2 weeks enrolment of about 1000 patients is expected. It is a cross-sectional survey, only follow-up is 30 day mortality. |
| Secondary outcome measures | 1. Causes of PH in the ICU setting 2. Diagnostic and therapeutic approach to PH by Swiss ICU physicians 3. 30 day outcome of patients admitted to ICU with suspected or confirmed PH During the planned study period of 2 weeks enrolment of about 1000 patients is expected. It is a cross-sectional survey, only follow-up is 30 day mortality. |
| Overall study start date | 01/09/2009 |
| Completion date | 30/09/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 1000 |
| Key inclusion criteria | All consecutive patients (no age limit or gender restrictions) admitted to ICU for any reason |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/09/2009 |
| Date of final enrolment | 30/09/2009 |
Locations
Countries of recruitment
- Switzerland
Study participating centre
University Hospital Zürich
Zürich
8091
Switzerland
8091
Switzerland
Sponsor information
Swiss Society of Pulmonary Hypertension (Switzerland)
Research organisation
Research organisation
c/o Institut für Medizin und Kommunikation (IMK) AG
Münsterberg 1
Basel
4001
Switzerland
| Website | http://www.imk.ch/Intro/WebHome |
|---|---|
"ROR" |
https://ror.org/02c518c71 |
Funders
Funder type
Research organisation
Swiss Society of Intensive Care Medicine (Switzerland)
No information available
Actelion Pharma Schweiz AG (Switzerland)
No information available
Lung League Ticino (Switzerland)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
